Popular biotech boosters getting multimillion-dollar payouts on Wall Street as top analysts are wooed with big offers — WSJ
If you’re one of those Wall Street analysts who enjoys nothing quite as much as building a fire of anticipation under a biotech stock, your day has arrived.
The Wall Street Journal today managed to track some of the big paydays awaiting the biotech analysts who have been jumping ship from one bank group to another. And there are three investment banks that are making some offers that are all but impossible to refuse: Leerink Partners, Cantor Fitzgerald and Jefferies Group.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.